📄 Nonselective beta-blockers may lead to stage 2 #AKI and waitlist mortality in child C cirrhosis‼️
⚠️ Use caution when using NSBBs in decompensated cirrhosis
#LiverTwitter #OpenAccess
journals.lww.com/hepcomm/fullte…
Hepatology Communications
1,757 posts
Hepatology Communications
@HepCommJournal
Hepatology Communications: Official open access journal of the AASLD (@AASLDtweets)| Co-editors in Chief: @ebtapper and Dr. Wong| #SoMe Editor: @jlouissaint89
- 📄 Ashwagandha-induced liver injury—A case series from India and literature review #Ashwagandha-HILI presents with cholestatic liver injury & can lead to death in those with pre-existing liver disease‼️ #LiverTwitter #HILI @theliverdoc @arifhussaintm journals.lww.com/hepcomm/fullte…
- 📑Is naltrexone safe in those with liver disease? 💊Naltrexone use was associated with ⬇️ AST/ALT in those without liver disease, with liver disease, and with cirrhosis 💊Of 160 subjects, no episodes of hepatotoxicity related to naltrexone doi.org/10.1002/hep4.2… #LiverTwitter
- 5.073!!! We are thrilled to share this news! Thank you to @GSzaboMD for her fearless leadership, to our AE’s and Ed Board, to @AASLDtweets, & to #livertwitter for choosing us with your work and reading our journal! @norahterrault @kymwatt @KowdleyMd @mandrekp @SekiEki @AdamMikMDAASLD is proud to announce its newest journal, @HepCommJournal - an online only, open-access journal - received an impressive first Impact Factor of 5.073. This places it in the top third of all journals in the #Gastroenterology/#Hepatology category.
- The @HepCommJournal team is here at @AASLDtweets #TLM22!! Our team is fired up and remains committed to the constructive, efficient and respectful review of your research!🔬🧬 #LiverTwitter #OpenAccess
- ⭐️⭐️ @HepCommJournal Editorial Board is here at @AASLDtweets #TLM23‼️⭐️⭐️ 💥We remain committed to the Respectful, Efficient (🕰️), and Constructive review of your research manuscripts! 📑 #LiverTwitter #OpenAccess journals.lww.com/hepcomm/pages/…
- 📑Moderate Alcohol Consumption is Associated with Significant #Fibrosis Progression in #NAFLD In a cohort with a mean 17(!) yrs of follow-up, mod alcohol use (🍷PETH > 48) ⬆️⬆️⬆️ risk of fibrosis progression (aOR 5.9) journals.lww.com/hepcomm/Fullte… #LiverTwitter
- We hear a lot about "leaky gut" in cirrhosis, but which gut segment is leaky and are certain bacteria 🧫 associated with leaky gut⁉️ Duodenum is the leakiest segment in cirrhosis, and certain bacteria are associated with leaky gut❕ #LiverTwitter journals.lww.com/hepcomm/fullte…
- 📑 Home exercise ➕branched-chain amino acids ➕ probiotics improve frailty in #cirrhosis‼️ 🌟 Patients randomized to exercise + BCAA + probiotics had ⬇️ in liver #frailty index, ⬇️ falls, and ⬇️ ER visits 🏥 ❕ journals.lww.com/hepcomm/fullte…
- 📄 Serum lactate and mean arterial pressure thresholds in patients with cirrhosis and septic shock 🦠 🚨Lactate >2 and median 24-hr MAP <65 associated with in-hospital mortality 💀 #LiverTwitter journals.lww.com/hepcomm/fullte…
- 📑 Increased accuracy in identifying #NAFLD with advanced fibrosis and cirrhosis! ⭐️ Agile 3+ & 4 scores performed superiorly to FIB-4 & LSM by VCTE & maintained good accuracy for diagnosis of adv fibrosis and cirrhosis! #LiverTwitter journals.lww.com/hepcomm/Fullte…
- 🌟The Hepatology Communications Editors would like to acknowledge and thank the journal's top peer reviewers for 2023🌟 THANK YOU to our top reviewers and all reviewers!
- 🚨Early Career Article Spotlight🚨 @LizzieAbyMD & @aly_kaplanMD Transplant Hep Fellows at @UMN_TxHep & @WCM_GI! ✅ out 📑: Cost and value in liver disease guidelines: 2011-2022 w/ senior mentorship from @NnekaUfereMD journals.lww.com/hepcomm/Fullte… #LiverTwitter #GITwitter #MedTwitter
- 📑 Multidisciplinary care for patients with #HCC is associated w ⬇️ mortality! ⭐️Increasingly important given the complexity of treatment decisions! #LiverTwitter #OncTwitter #RadsTwitter #OpenAccess journals.lww.com/hepcomm/Fullte…
